Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > Medtronic Undergoes Leadership Shakeup Amid Sweeping Transformation

Medtronic Undergoes Leadership Shakeup Amid Sweeping Transformation

ECHEMI 2024-07-08

Medtronic, the global medical technology company, has announced significant changes to its executive leadership team. In a statement, Rob Hoedt, Executive Vice President and President of Medtronic's global regions, revealed that he will be retiring from his distinguished career on June 28th, opting to start his retirement journey earlier than the company's mandatory retirement age of 65. At 63 years old, ten Hoedt has decided to forgo the remainder of his professional tenure and embark on a new chapter of his retirement life.

 

Additionally, Karen Parkhill, Executive Vice President and Chief Financial Officer of Medtronic, has announced her plans to depart the company and join the renowned HP Inc. as their new CFO. To ensure the continuity of the company's financial operations, Medtronic has initiated the search for a suitable successor, which may come from within the organization or be an external candidate of exceptional caliber. In the interim, Gary Corona, Senior Vice President of Global Financial Planning and Analysis, will temporarily assume the CFO responsibilities to facilitate a smooth transition.

 

This year has been a tumultuous one for Medtronic, marked by a series of high-level executive departures. In addition to ten Hoedt and Parkhill's exits, the company has seen the departures of several other senior leaders, including Gio DiNapoli, President of the Gastrointestinal business; Ariel Mactavish, President of the Respiratory Interventions business; Bob White, Executive Vice President and President of the Medical Surgical Portfolio; and Christopher Cleary, Senior Vice President of Corporate Development.

 

The challenges facing Medtronic this year are part of a comprehensive transformation plan. In February, the company announced the closure of its Respiratory business unit, accompanied by a global workforce reduction, the implementation of an early retirement program, stricter cost control measures, and increased investments in automation, digitalization, and strategic research and development to support the company's future growth. These reform initiatives have been a significant driver behind the recent extensive leadership changes.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.